000 01665 a2200469 4500
005 20250515082553.0
264 0 _c20080131
008 200801s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.10820
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMateos-Mazon, Juan
245 0 0 _aUse of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation.
_h[electronic resource]
260 _bHaematologica
_cSep 2007
300 _a1295-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBoronic Acids
_xtherapeutic use
650 0 4 _aBortezomib
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGraft vs Host Disease
_xprevention & control
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xcomplications
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aPyrazines
_xtherapeutic use
650 0 4 _aSalvage Therapy
650 0 4 _aTransplantation Conditioning
_xmethods
650 0 4 _aTransplantation, Homologous
650 0 4 _aTreatment Outcome
700 1 _aPérez-Simón, José-Antonio
700 1 _aLopez, Olga
700 1 _aHernández, Emiliano
700 1 _aEtxebarria, Jaime
700 1 _aSan Miguel, Jésus F
773 0 _tHaematologica
_gvol. 92
_gno. 9
_gp. 1295-6
856 4 0 _uhttps://doi.org/10.3324/haematol.10820
_zAvailable from publisher's website
999 _c17297182
_d17297182